Duan L, Zaepfel BL, Aksenova V, Dasso M, Rothstein JD, Kalab P et al (2022) Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export. Cell Rep 40:111106
Article PubMed PubMed Central CAS Google Scholar
François-Moutal L, Perez-Miller S, Scott DD, Miranda VG, Mollasalehi N, Khanna M (2019) Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front Mol Neurosci 12:301
Article PubMed PubMed Central Google Scholar
Song J (2024) Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43. Aging Dis 15:2084–2112
Article PubMed PubMed Central Google Scholar
Keating SS, San Gil R, Swanson MEV, Scotter EL, Walker AK (2022) TDP-43 pathology: From noxious assembly to therapeutic removal. Prog Neurobiol 211:102229
Article PubMed CAS Google Scholar
de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T et al (2020) TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry 92:86–95
Ou SH, Wu F, Harrich D, García-Martínez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69:3584–3596
Article PubMed PubMed Central CAS Google Scholar
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133
Article PubMed CAS Google Scholar
Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427–434
Article PubMed CAS Google Scholar
Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672
Article PubMed PubMed Central CAS Google Scholar
Neumann M (2009) Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci 10:232–246
Article PubMed PubMed Central CAS Google Scholar
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256
Article PubMed PubMed Central CAS Google Scholar
Liu R, Yang G, Nonaka T, Arai T, Jia W, Cynader MS (2013) Reducing TDP-43 aggregation does not prevent its cytotoxicity. Acta Neuropathol Commun 1:49
Article PubMed PubMed Central Google Scholar
Tseng Y-L, Lu P-C, Lee C-C, He R-Y, Huang Y-A, Tseng Y-C et al (2023) Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera. J Biomed Sci 30:27
Article PubMed PubMed Central CAS Google Scholar
Francois-Moutal L, Scott DD, Khanna M (2021) Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape. RSC Chem Biol 2:1158–1166
Article PubMed PubMed Central CAS Google Scholar
Acharya KK, Govind CK, Shore AN, Stoler MH, Reddi PP (2006) cis-requirement for the maintenance of round spermatid-specific transcription. Dev Biol 295:781–790
Article PubMed CAS Google Scholar
Giannini M, Bayona-Feliu A, Sproviero D, Barroso SI, Cereda C, Aguilera A (2020) TDP-43 mutations link Amyotrophic Lateral Sclerosis with R-loop homeostasis and R loop-mediated DNA damage. PLoS Genet 16:e1009260
Article PubMed PubMed Central CAS Google Scholar
Wood M, Quinet A, Lin Y-L, Davis AA, Pasero P, Ayala YM et al (2020) TDP-43 dysfunction results in R-loop accumulation and DNA replication defects. J Cell Sci 133
Mitra J, Guerrero EN, Hegde PM, Liachko NF, Wang H, Vasquez V et al (2019) Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci U S A 116:4696–4705
Article PubMed PubMed Central CAS Google Scholar
Passoni M, De Conti L, Baralle M, Buratti E (2012) UG repeats/TDP-43 interactions near 5’ splice sites exert unpredictable effects on splicing modulation. J Mol Biol 415:46–60
Article PubMed CAS Google Scholar
Dreumont N, Hardy S, Behm-Ansmant I, Kister L, Branlant C, Stévenin J et al (2010) Antagonistic factors control the unproductive splicing of SC35 terminal intron. Nucleic Acids Res 38:1353–1366
Article PubMed CAS Google Scholar
Bose JK, Wang I-F, Hung L, Tarn W-Y, Shen C-KJ (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem 283:28852–28859
Article PubMed PubMed Central CAS Google Scholar
Gumina V, Colombrita C, Fallini C, Bossolasco P, Maraschi AM, Landers JE et al (2019) TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene. Biochim Biophys acta Gene Regul Mech 1862:194413
Article PubMed PubMed Central CAS Google Scholar
Deshaies J-E, Shkreta L, Moszczynski AJ, Sidibé H, Semmler S, Fouillen A et al (2018) TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141:1320–1333
Article PubMed PubMed Central Google Scholar
Guo L, Ke H, Zhang H, Zou L, Yang Q, Lu X et al (2022) TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms. Cell Death Dis 13:428
Article PubMed PubMed Central CAS Google Scholar
Majumder P, Chu J-F, Chatterjee B, Swamy KBS, Shen C-KJ (2016) Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP. Acta Neuropathol 132:721–738
Article PubMed PubMed Central CAS Google Scholar
Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y et al (2011) Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 286:1204–1215
Article PubMed CAS Google Scholar
Gu J, Wu F, Xu W, Shi J, Hu W, Jin N et al (2017) TDP-43 suppresses tau expression via promoting its mRNA instability. Nucleic Acids Res 45:6177–6193
Article PubMed PubMed Central CAS Google Scholar
Ayala YM, De Conti L, Avendaño-Vázquez SE, Dhir A, Romano M, D’Ambrogio A et al (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30:277–288
Article PubMed CAS Google Scholar
Tank EM, Figueroa-Romero C, Hinder LM, Bedi K, Archbold HC, Li X et al (2018) Abnormal RNA stability in amyotrophic lateral sclerosis. Nat Commun 9:2845
Article PubMed PubMed Central CAS Google Scholar
Liu X, L
留言 (0)